Terms: = Ovarian cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118
8 results:
1. WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.
Embaby A; Kutzera J; Geenen JJ; Pluim D; Hofland I; Sanders J; Lopez-Yurda M; Beijnen JH; Huitema ADR; Witteveen PO; Steeghs N; van Haaften G; van Vugt MATM; de Ridder J; Opdam FL
Gynecol Oncol; 2023 Jul; 174():239-246. PubMed ID: 37236033
[TBL] [Abstract] [Full Text] [Related]
2. New insights into
Wang J; Wang K
Front Cell Infect Microbiol; 2022; 12():1029178. PubMed ID: 36329823
[No Abstract] [Full Text] [Related]
3. LncRNA lifr-AS1 overexpression suppressed the progression of serous ovarian carcinoma.
Liu F; Cao L; Zhang Y; Xia X; Ji Y
J Clin Lab Anal; 2022 Aug; 36(8):e25470. PubMed ID: 35778954
[TBL] [Abstract] [Full Text] [Related]
4. Susceptibility-weighted MR sequence for the evaluation of ovarian masses with torsion.
Takeuchi M; Matsuzaki K; Harada M
Br J Radiol; 2020 May; 93(1109):20200110. PubMed ID: 32208978
[TBL] [Abstract] [Full Text] [Related]
5. Imaging in gynecological disease (9): clinical and ultrasound characteristics of tubal cancer.
Ludovisi M; De Blasis I; Virgilio B; Fischerova D; Franchi D; Pascual MA; Savelli L; Epstein E; Van Holsbeke C; Guerriero S; Czekierdowski A; Zannoni G; Scambia G; Jurkovic D; Rossi A; Timmerman D; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):328-35. PubMed ID: 23893713
[TBL] [Abstract] [Full Text] [Related]
6. Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.
Choi CH; Choi JJ; Park YA; Lee YY; Song SY; Sung CO; Song T; Kim MK; Kim TJ; Lee JW; Kim HJ; Bae DS; Kim BG
Br J Cancer; 2012 Jun; 107(1):91-9. PubMed ID: 22644307
[TBL] [Abstract] [Full Text] [Related]
7. Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial.
Aisner J; Musanti R; Beers S; Smith S; Locsin S; Rubin EH
Clin Cancer Res; 2003 Jul; 9(7):2504-9. PubMed ID: 12855624
[TBL] [Abstract] [Full Text] [Related]
8. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
[TBL] [Abstract] [Full Text] [Related]
